The conversation around cannabis-derived products often starts with legality, but their health benefits are gaining scientific backing. Canada legalized recreational marijuana on October 17, 2018, yet globally, low- or no-THC products like CBD dominate legal markets. These could soon surpass pure cannabis sales.
In the U.S., over a dozen states permit edibles, with sales exceeding early projections. Drawing from established research, including insights from Harvard Health Publishing, this article explores proven benefits of medical cannabis and CBD oil, now accessible in most countries.
Cannabis compounds show real medical potential, supported by growing studies. Below are key examples—not exhaustive, but grounded in evidence.
THC in medical marijuana effectively eases:
For chronic pain affecting millions worldwide, medical cannabis offers relief where stronger options fall short, like post-surgical or acute injuries. It's safer than opioids—virtually no overdose risk and low addiction potential—and serves as an alternative to NSAIDs like ibuprofen or naproxen for those with kidney issues or ulcers.
Particularly effective for multiple sclerosis and nerve pain, it outperforms sedating drugs like Neurontin, Lyrica, or opioids, helping patients reclaim daily activities without fog.
As a muscle relaxant, it reduces Parkinson’s tremors and aids fibromyalgia, endometriosis, interstitial cystitis, and other chronic pain conditions.
Cannabis also combats nausea, supports weight management, and shows promise for PTSD in veterans—with reports of significant improvements prompting calls for more research and fewer restrictions.
It's helped HIV patients with pain and wasting, plus irritable bowel syndrome and Crohn’s. Always evaluate claims critically, as with any treatment.
Users turn to CBD for arthritis, Crohn’s, diabetes, multiple sclerosis (often with THC), anxiety, insomnia, and pain. Evidence remains limited for most, though.
The FDA recently approved Epidiolex, the first CBD drug, for rare childhood epilepsies. Studies also highlight its antibiotic properties.
Over 160 CBD trials are underway per the NIH database, signaling robust ongoing research.
